ACVD and the Biotech Industry

ACVD will promote the development of new immunotherapeutic technologies through establishment of collaborative links between its member laboratories and the international biotech industry. ACVD also offers consultancy services and contract research to industry based on the diverse expertise it has available at QIMR.

ACVD member laboratories have extensive experience in infectious diseases, cancer therapies, organ transplantation and vaccine testing. ACVD laboratories are equipped with world-class technologies which can provide facilities for both preclinical and clinical testing of novel vaccine formulations. ACVD group leaders are internationally recognised scientists in their fields and are able to provide expert advice on various aspects of vaccine related research and development.

Specific Expertise available at ACVD

• Ex vivo analysis of human and murine immune response
  
• Preclinical models for infectious diseases (malaria, Leishmania, EBV, CMV, hookworm, schistosomiasis, scabies, Group A streptococcus, Giardia, Trichomonas and Entamoeba), cancer (Hodgkin’s lymphoma, melanoma, nasopharyngeal carcinoma, non-Hodgkin’s lymphoma) and transplantation (stem cell transplant)
  
• Bioinformatics and T cell epitope mapping
  
• Production of preclinical/clinical grade immunotherapies for infectious diseases and human cancers
  
• Expression and production of recombinant proteins and monoclonal antibodies
  
• Clinical immune monitoring for vaccine studies
  
• Phase I/II/III clinical trial design